Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response

被引:100
|
作者
Zhang, XS
Succi, J
Feng, ZH
Prithivirajsingh, S
Story, MD
Legerski, RJ
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX USA
[3] Univ Texas, MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX USA
关键词
D O I
10.1128/MCB.24.20.9207-9220.2004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in Artemis in both humans and mice result in severe combined immunodeficiency due to a defect in V(D)J recombination. In addition, Artemis mutants are radiosensitive and chromosomally unstable, which has been attributed to a defect in nonhomologous end joining (NHEJ). We show here, however, that Artemis-depleted cell extracts are not defective in NHEJ and that Artemis-deficient cells have normal repair kinetics of double-strand breaks after exposure to ionizing radiation (IR). Artemis is shown, however, to interact with known cell cycle checkpoint proteins and to be a phosphorylation target of the checkpoint kinase ATM or ATR after exposure of cells to IR or UV irradiation, respectively. Consistent with these findings, our results also show that Artemis is required for the maintenance of a normal DNA damage-induced G(2)/M cell cycle arrest. Artemis does not appear, however, to act either upstream or downstream of checkpoint kinase Chk1 or Chk2. These results define Artemis as having a checkpoint function and suggest that the radiosensitivity and chromosomal instability of Artemis-deficient cells may be due to defects in cell cycle responses after DNA damage.
引用
收藏
页码:9207 / 9220
页数:14
相关论文
共 50 条
  • [21] CyclinG contributes to G2/M arrest of cells in response to DNA damage
    Shimizu, A
    Nishida, J
    Ueoka, Y
    Kato, K
    Hachiya, T
    Kuriaki, Y
    Wake, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) : 529 - 533
  • [22] G2 checkpoint control - Checking in to the last resort for DNA damage
    Jackson, JR
    Zhou, BB
    CANCER BIOLOGY & THERAPY, 2004, 3 (03) : 314 - 316
  • [23] A quantitative analysis of the kinetics of the G2 DNA damage checkpoint system
    Aguda, BD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11352 - 11357
  • [24] Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress
    Liu, Shengqin
    Opiyo, Stephen O.
    Manthey, Karoline
    Glanzer, Jason G.
    Ashley, Amanda K.
    Amerin, Courtney
    Troksa, Kyle
    Shrivastav, Meena
    Nickoloff, Jac A.
    Oakley, Greg G.
    NUCLEIC ACIDS RESEARCH, 2012, 40 (21) : 10780 - 10794
  • [25] Role for hACF1 in the G2/M damage checkpoint
    Sanchez-Molina, Sara
    Mortusewicz, Oliver
    Bieber, Beatrice
    Auer, Susanne
    Eckey, Maren
    Leonhardt, Heinrich
    Friedl, Anna A.
    Becker, Peter B.
    NUCLEIC ACIDS RESEARCH, 2011, 39 (19) : 8445 - 8456
  • [26] Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation
    Lee, Min-Young
    Kim, Hyun-Ju
    Kim, Myoung-Ae
    Jee, Hye Jin
    Kim, Ae Jeong
    Bae, Yoe-Sik
    Park, Joo-In
    Chung, Jay H.
    Yun, Jeanho
    CELL CYCLE, 2008, 7 (17) : 2705 - 2709
  • [27] Mcm2 is a direct substrate of ATM and ATR during DNA damage and DNA replication checkpoint responses
    Yoo, HY
    Shevchenko, A
    Shevchenko, A
    Dunphy, WG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) : 53353 - 53364
  • [28] JNK-mediated Phosphorylation of Cdc25C Regulates Cell Cycle Entry and G2/M DNA Damage Checkpoint
    Gutierrez, Gustavo J.
    Tsuji, Toshiya
    Cross, Janet V.
    Davis, Roger J.
    Templeton, Dennis J.
    Jiang, Wei
    Ronai, Ze'ev A.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (19) : 14217 - 14228
  • [29] Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines
    Nakagawa, T
    Hayashita, Y
    Maeno, K
    Masuda, A
    Sugito, N
    Osada, H
    Yanagisawa, K
    Ebi, H
    Shimokata, K
    Takahashi, T
    CANCER RESEARCH, 2004, 64 (14) : 4826 - 4832
  • [30] The Mre11 complex is required for ATM activation and the G2/M checkpoint
    Carson, CT
    Schwartz, RA
    Stracker, TH
    Lilley, CE
    Lee, DV
    Weitzman, MD
    EMBO JOURNAL, 2003, 22 (24): : 6610 - 6620